Revenue | ₹2.00Cr |
Net Profits | ₹0.72Cr |
Net Profit Margins | -36.00% |
Norris Medicines Ltd’s revenue jumped 57.48% since last year same period to ₹2.00Cr in the Q2 2025-2026. On a quarterly growth basis, Norris Medicines Ltd has generated 35.14% jump in its revenue since last 3-months.
Norris Medicines Ltd’s net profit fell -100% since last year same period to ₹0.72Cr in the Q2 2025-2026. On a quarterly growth basis, Norris Medicines Ltd has generated -132.26% fall in its net profits since last 3-months.
Norris Medicines Ltd’s net profit margin fell -27% since last year same period to -36.00% in the Q2 2025-2026. On a quarterly growth basis, Norris Medicines Ltd has generated -71.87% fall in its net profit margins since last 3-months.
The revenue for Norris Medicines Ltd in the Q2 results 2025 was ₹2.00Cr.
The net profit for Norris Medicines Ltd in the Q2 results 2025 was ₹0.72Cr.
The net profit margin for Norris Medicines Ltd in the Q2 results 2025 was -36.00%.
The revenue for Norris Medicines Ltd in the Q2 results 2024 was ₹1.27Cr.
The net profit for Norris Medicines Ltd in the Q2 results 2024 was ₹0.36Cr.
The net profit margin for Norris Medicines Ltd in the Q2 results 2024 was -28.35%.